EDGAR Filing Documents for 0001193125-21-092693

Form 8-K - Current report:

SEC Accession No. 0001193125-21-092693

Filing Date

2021-03-24

Accepted

2021-03-24 16:37:02

Documents

Period of Report

2021-03-23

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d119670d8k.htm	8-K	18770
2	EX-99.1	d119670dex991.htm	EX-99.1	46505
3	GRAPHIC	g119670logo.jpg	GRAPHIC	4351
	Complete submission text file	0001193125-21-092693.txt		72714

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306

Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676

Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 21768580
SIC: 2834 Pharmaceutical Preparations